These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 20399544)
1. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. Refaat HM Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives. Luo Y; Xiao F; Qian S; Lu W; Yang B Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives. El-Nassan HB Eur J Med Chem; 2012 Jul; 53():22-7. PubMed ID: 22542105 [TBL] [Abstract][Full Text] [Related]
4. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells. Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents. Rida SM; Ashour FA; El-Hawash SA; ElSemary MM; Badr MH; Shalaby MA Eur J Med Chem; 2005 Sep; 40(9):949-59. PubMed ID: 16040162 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents. Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694 [TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents. Gellis A; Kovacic H; Boufatah N; Vanelle P Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity. Paul K; Bindal S; Luxami V Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480 [TBL] [Abstract][Full Text] [Related]
10. Benzimidazole condensed ring systems. XII. Synthesis and anticancer evaluation of certain pyrido[1,2-a]benzimidazole derivatives. el-Hawash SA; Badawey el-S A; Kappe T Pharmazie; 1999 May; 54(5):341-6. PubMed ID: 10368827 [TBL] [Abstract][Full Text] [Related]
11. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives. Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544 [TBL] [Abstract][Full Text] [Related]
13. Microwave supported synthesis of some novel 1,3-diarylpyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities. Demirayak S; Kayagil I; Yurttas L Eur J Med Chem; 2011 Jan; 46(1):411-6. PubMed ID: 21122952 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles. Singh M; Tandon V Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. Ozkay Y; Işikdağ I; Incesu Z; Akalin G Eur J Med Chem; 2010 Aug; 45(8):3320-8. PubMed ID: 20451307 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines. Stýskala J; Stýskalová L; Slouka J; Hajdúch M Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Rostom SA; Ashour HM; Abd El Razik HA Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663 [TBL] [Abstract][Full Text] [Related]
18. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents. Abdel-Mohsen HT; Ragab FA; Ramla MM; El Diwani HI Eur J Med Chem; 2010 Jun; 45(6):2336-44. PubMed ID: 20356655 [TBL] [Abstract][Full Text] [Related]
19. One-pot double intramolecular homolytic aromatic substitution routes to dialicyclic ring fused imidazobenzimidazolequinones and preliminary analysis of anticancer activity. Fagan V; Bonham S; Carty MP; Aldabbagh F Org Biomol Chem; 2010 Jul; 8(14):3149-56. PubMed ID: 20485753 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives. Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]